Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CytRx Corp (NASDAQ:CYTR)

0.6008
Delayed Data
As of Aug 26
 +0.0108 / +1.83%
Today’s Change
0.55
Today|||52-Week Range
3.66
-77.33%
Year-to-Date

Today’s Trading

Previous close0.59
Today’s open0.59
Day’s range0.58 - 0.61
Volume1,807,166
Average volume (3 months)2,038,660
Market cap$58.2M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-76.36%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,602.80
Price/Book0.91

Competitors

 Today’s
change
Today’s
% change
PLXProtalix Biotherapeu...-0.01-1.04%
APVOAptevo Therapeutics ...+0.04+1.34%
CRMDCorMedix Inc+0.02+1.27%
TENXTenax Therapeutics I...-0.04-1.67%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$100.0K
Annual profit (last year)-$58.6M
Net profit margin-58,587.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Steven A. Kriegsman
Chief Financial Officer &
Treasurer
John Y. Caloz
Corporate headquarters
Los Angeles, California

Forecasts

Partner Offers

Search for Jobs